Portfolio company
B2H
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This platform provides translational medicine and cell therapy services to life sciences companies and entrepreneurs within the healthcare ecosystem.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
AdThera
The company provides process development and manufacturing services for cell and gene therapies to biotechnology firms and academic centres.
BioHive
BioHive provides skin organoids derived from stem cells to pharmaceutical and dermocosmetic companies for toxicity and efficacy testing.
Cellares
This company provides automated manufacturing platforms and services for cell therapy development to biopharmaceutical organisations and academic research centres.
HemostOD
The company develops stem cell-derived platelets for transfusion and targeted drug delivery, serving healthcare providers and pharmaceutical partners treating blood disorders or trauma.
Salve Therapeutics
The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.
D2G Oncology
This company develops genomic drug screening platforms and mouse models to identify genotype-specific cancer treatments for healthcare institutions and pharmaceutical researchers.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
